News from Apogenix A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jan 13, 2014, 09:00 ET
Jan 07, 2014, 09:00 ET

Apogenix to Present Phase II Results with APG101 for the Treatment of Recurrent Glioblastoma at Biotech Showcase in San Francisco

 Apogenix, a clinical stage biopharmaceutical company, announced today that Thomas Hoeger, Ph.D., Chief Executive Officer, will...

Dec 05, 2013, 09:00 ET

Apogenix' APG350 Effectively Induces Apoptosis of Tumor Cells via TRAIL Pathway Independent of Fc-gamma Cross-Linking

 Apogenix, a clinical stage biopharmaceutical company, announced today that the data published in the December issue of Molecular Cancer...

Jul 02, 2013, 09:00 ET

Apogenix Strengthens Patent Position for Apocept™ (APG101) in Europe and Canada

 Apogenix GmbH, a clinical stage biopharmaceutical company developing novel protein therapeutics for the treatment of cancer and inflammatory...

Feb 07, 2013, 09:00 ET

Apogenix Receives FDA Orphan Drug Designation for Apocept™ to Treat Myelodysplastic Syndromes and Initiates Clinical Phase I Study

Apogenix GmbH, a clinical stage biopharmaceutical company developing novel protein therapeutics for the treatment of cancer and inflammatory...

Nov 06, 2012, 04:00 ET

Apogenix's Apocept™ for Glioblastoma Multiforme Named One of "Top 10 Projects to Watch"

Apogenix, a clinical stage biopharmaceutical company developing novel protein therapeutics for the treatment of cancer and inflammatory...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge